Works matching IS 13518216 AND DT 2017 AND VI 23 AND IP 1

Results: 31

Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 50, doi. 10.1111/hae.13033

By:

Amano, K.;
Seita, I.;
Higasa, S.;
Sawada, A.;
Kuwahara, M.;
Shima, M.

Publication type:

Article

Trunk muscle activation characteristics in patients with severe haemophilia.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 122, doi. 10.1111/hae.13037

By:

Kurz, E.;
Herbsleb, M.;
Grassme, R.;
Anders, C.;
Hilberg, T.

Publication type:

Article

Recombinant porcine sequence factor VIII (rp FVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 25, doi. 10.1111/hae.13040

By:

Tarantino, M. D.;
Cuker, A.;
Hardesty, B.;
Roberts, J. C.;
Sholzberg, M.

Publication type:

Article

Low-factor consumption for major surgery in haemophilia B with long-acting recombinant glyco PEGylated factor IX.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 67, doi. 10.1111/hae.13041

By:

Escobar, M. A.;
Tehranchi, R.;
Karim, F. A.;
Caliskan, U.;
Chowdary, P.;
Colberg, T.;
Giangrande, P.;
Giermasz, A.;
Mancuso, M. E.;
Serban, M.;
Tsay, W.;
Mahlangu, J. N.

Publication type:

Article

Long-term outcome of total hip arthroplasty in patients with haemophilia.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 129, doi. 10.1111/hae.13045

By:

Strauss, A. C.;
Rommelspacher, Y.;
Nouri, B.;
Bornemann, R.;
Wimmer, M. D.;
Oldenburg, J.;
Pennekamp, P. H.;
Schmolders, J.

Publication type:

Article

Physician trust and depression influence adherence to factor replacement: a single-centre cross-sectional study.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 98, doi. 10.1111/hae.13078

By:

Tran, D. Q.;
Barry, V.;
Antun, A.;
Ribeiro, M.;
Stein, S.;
Kempton, C. L.

Publication type:

Article

Low dose prophylaxis in Tunisian children with haemophilia.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 77, doi. 10.1111/hae.13048

By:

Gouider, E.;
Jouini, L.;
Achour, M.;
Elmahmoudi, H.;
Zahra, K.;
Saied, W.;
Meddeb, B.

Publication type:

Article

Efficacy and safety of point-of-care ultrasound-guided intra-articular corticosteroid joint injections in patients with haemophilic arthropathy.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 135, doi. 10.1111/hae.13057

By:

Martin, E. J.;
Cooke, E. J.;
Ceponis, A.;
Barnes, R. F. W.;
Moran, C. M.;
Holle, S.;
Hughes, T. H.;
Moore, R. E.;
Drygalski, A.

Publication type:

Article

Relative contributions of bleeding scores and iron status on health-related quality of life in von Willebrand disease: a cross-sectional study.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 115, doi. 10.1111/hae.13062

By:

Xu, Y.;
Deforest, M.;
Grabell, J.;
Hopman, W.;
James, P.

Publication type:

Article

The impact of a haemophilia education intervention on the knowledge and health related quality of life of parents of Indian children with haemophilia.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 82, doi. 10.1111/hae.13070

By:

Phadnis, S.;
Kar, A.

Publication type:

Article

The demographics, treatment characteristics and quality of life of adult people with haemophilia in China - results from the HERO study.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 89, doi. 10.1111/hae.13071

By:

Sun, J.;
Zhao, Y.;
Yang, R.;
Guan, T.;
Iorio, A.;
Wang, Xuefeng;
Wu, Jingsheng;
Zhang, Xinsheng;
Teng, Bin;
Li, Kuixing;
Guan, Tao;
Chu, Yuguang;
Huang, Zikai

Publication type:

Article

A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X ( MC710) in haemophilia patients with inhibitors.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 59, doi. 10.1111/hae.13050

By:

Shinkoda, Y.;
Shirahata, A.;
Fukutake, K.;
Takamatsu, J.;
Shima, M.;
Hanabusa, H.;
Mugishima, H.;
Takedani, H.;
Kawasugi, K.;
Taki, M.;
Matsushita, T.;
Tawa, A.;
Nogami, K.;
Higasa, S.;
Kosaka, Y.;
Fujii, T.;
Sakai, M.;
Migita, M.;
Uchiba, M.;
Kawakami, K.

Publication type:

Article

RCT - subjective physical performance and quality of life after a 6-month programmed sports therapy (PST) in patients with haemophilia.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 144, doi. 10.1111/hae.13079

By:

Runkel, B.;
Von Mackensen, S.;
Hilberg, T.

Publication type:

Article

Visualization of haemophilic arthropathy in F8−/− rats by ultrasonography and micro-computed tomography.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 152, doi. 10.1111/hae.13080

By:

Christensen, K. R.;
Roepstorff, K.;
Petersen, M.;
Wiinberg, B.;
Hansen, A. K.;
Kjelgaard‐Hansen, M.;
Nielsen, L. N.

Publication type:

Article

Recombinant B-domain-deleted porcine sequence factor VIII (r- pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitors.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 33, doi. 10.1111/hae.13108

By:

Mahlangu, J. N.;
Andreeva, T. A.;
Macfarlane, D. E.;
Walsh, C.;
Key, N. S.

Publication type:

Article

Pilot study on 18F-FDG PET/CT for detection of inflammatory changes in blood-induced knee arthropathy in a rabbit model.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e25, doi. 10.1111/hae.13090

By:

Shammas, A.;
Doria, A. S.;
Amirabadi, A.;
Gahunia, H.;
Jong, R.;
Charron, M.;
Moineddin, R.;
Metser, U.

Publication type:

Article

Instructions to Authors.

Published in:: Haemophilia, 2017, v. 23, n. 1, p. 164, doi. 10.1111/hae.13092
Publication type:: Article

Issue Information.

Published in:: Haemophilia, 2017, v. 23, n. 1, p. 1, doi. 10.1111/hae.13093
Publication type:: Article

The importance of mRNA structure in determining the pathogenicity of synonymous and non-synonymous mutations in haemophilia.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e8, doi. 10.1111/hae.13107

By:

Hamasaki‐Katagiri, N.;
Lin, B. C.;
Simon, J.;
Hunt, R. C.;
Schiller, T.;
Russek‐Cohen, E.;
Komar, A. A.;
Bar, H.;
Kimchi‐Sarfaty, C.

Publication type:

Article

Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 11, doi. 10.1111/hae.13088

By:

Fischer, K.;
Poonnoose, P.;
Dunn, A. L.;
Babyn, P.;
Manco‐Johnson, M. J.;
David, J. A.;
Net, J.;
Feldman, B.;
Berger, K.;
Carcao, M.;
Kleijn, P.;
Silva, M.;
Hilliard, P.;
Doria, A.;
Srivastava, A.;
Blanchette, V.;
Avila, Laura;
Boma‐Fischer, Laurence;
Brandao, Leonardo;
Busch, Michael T.

Publication type:

Article

European retrospective study of real-life haemophilia treatment.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 105, doi. 10.1111/hae.13111

By:

Berntorp, E.;
Dolan, G.;
Hay, C.;
Linari, S.;
Santagostino, E.;
Tosetto, A.;
Castaman, G.;
Álvarez‐Román, MT.;
Parra Lopez, R.;
Oldenburg, J.;
Albert, T.;
Scholz, U.;
Holmström, M.;
Schved, J.‐F.;
Trossaërt, M.;
Hermans, C.;
Boban, A.;
Ludlam, C.;
Lethagen, S.

Publication type:

Article

Clinical characteristics of two patients with α1-antitrypsin Pittsburgh in a Chinese family.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e33, doi. 10.1111/hae.13113

By:

Cao, L.;
Wang, Z.;
Bai, X.;
Yu, Z.;
Su, J.;
Ruan, C.

Publication type:

Article

Prevalence and predictors of loss to follow-up in young adults with mild haemophilia.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e36, doi. 10.1111/hae.13114

By:

Sun, H. (L.);
McIntosh, K.;
Woo, C.;
Crilly, E.;
Bartholomew, C.;
Gue, D.;
De Marchi, L.;
Squire, S.;
Silva, A.;
Yang, M.;
Wu, J. K.;
Jackson, S.

Publication type:

Article

Possible assessment of coagulation function and haemostasis therapy using comprehensive coagulation assays in a patient with acquired haemophilia A.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e46, doi. 10.1111/hae.13134

By:

Takeyama, M.;
Nogami, K.;
Matsumoto, T.;
Taguchi, M.;
Yada, K.;
Okahashi, N.;
Amano, I.;
Kimura, H.;
Shima, M.

Publication type:

Article

Measuring the quality of haemophilia care across different settings: a set of performance indicators derived from demographics data.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e1, doi. 10.1111/hae.13127

By:

Iorio, A.;
Stonebraker, J. S.;
Brooker, M.;
Soucie, J. M.;
Bolton‐Maggs, Paula;
El‐Ekiaby, Magdy;
Makris, Michael;
Noone, Declan;
Srivastava, Alok;
Rezende, Suely M.;
Berg, Marijke;
Windyga, Jerzy

Publication type:

Article

Balance evaluation in haemophilic preadolescent patients using Nintendo Wii Balance Board®.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e18, doi. 10.1111/hae.13128

By:

Pérez‐Alenda, S.;
Carrasco, J. J.;
Aguilar‐Rodríguez, M.;
Martínez‐Gómez, L.;
Querol‐Giner, M.;
Cuesta‐Barriuso, R.;
Torres‐Ortuño, A.;
Querol, F.

Publication type:

Article

Determining the health-related quality of life in individuals with haemophilia in developing economies: results from the Brazilian population.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. 42, doi. 10.1111/hae.13130

By:

Salomon, T.;
Chaves, D. G.;
Brener, S.;
Martins, P. R. J.;
Mambrini, J. V. M.;
Peixoto, S. V.

Publication type:

Article

Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e43, doi. 10.1111/hae.13131

By:

Ragni, M. V.;
Yabes, J. G.;
Fogarty, P. F.;
Josephson, N. C.;
Kessler, C. M.;
Neff, A. T.;
Raffini, L.;
Brummel‐Ziedins, K.;
Moore, C. G.

Publication type:

Article

Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein ( rFVIIIFc) in the A-LONG and Kids A- LONG Studies.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e39, doi. 10.1111/hae.13125

By:

Quon, D. V.;
Klamroth, R.;
Kulkarni, R.;
Shapiro, A. D.;
Baker, R. I.;
Castaman, G.;
Kerlin, B. A.;
Tsao, E.;
Allen, G.

Publication type:

Article

Experience of tailoring prophylaxis using factor VIII pharmacokinetic parameters estimated with myPKFiT® in patients with severe haemophilia A without inhibitors.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e50, doi. 10.1111/hae.13141

By:

Álvarez‐Román, M. T.;
Fernandez‐Bello, I.;
Corte‐Rodríguez, H.;
Hernández‐Moreno, A. L.;
Martín‐Salces, M.;
Butta‐Coll, N.;
Rivas‐Pollmar, M. I.;
Rivas‐Muñoz, S.;
Jiménez‐Yuste, V.

Publication type:

Article

Rapid identification of the intron 22 inversion in haemophilia A.

Published in:

Haemophilia, 2017, v. 23, n. 1, p. e55, doi. 10.1111/hae.13142

By:

Kloppers, Jean F.;
Janse van Rensburg, Walter J.

Publication type:

Article

Works matching IS 13518216 AND DT 2017 AND VI 23 AND IP 1

Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data.

Trunk muscle activation characteristics in patients with severe haemophilia.

Recombinant porcine sequence factor VIII (rp FVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients.

Low-factor consumption for major surgery in haemophilia B with long-acting recombinant glyco PEGylated factor IX.

Long-term outcome of total hip arthroplasty in patients with haemophilia.

Physician trust and depression influence adherence to factor replacement: a single-centre cross-sectional study.

Low dose prophylaxis in Tunisian children with haemophilia.

Efficacy and safety of point-of-care ultrasound-guided intra-articular corticosteroid joint injections in patients with haemophilic arthropathy.

Relative contributions of bleeding scores and iron status on health-related quality of life in von Willebrand disease: a cross-sectional study.

The impact of a haemophilia education intervention on the knowledge and health related quality of life of parents of Indian children with haemophilia.

The demographics, treatment characteristics and quality of life of adult people with haemophilia in China - results from the HERO study.

A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X ( MC710) in haemophilia patients with inhibitors.

RCT - subjective physical performance and quality of life after a 6-month programmed sports therapy (PST) in patients with haemophilia.

Visualization of haemophilic arthropathy in F8<sup>−/−</sup> rats by ultrasonography and micro-computed tomography.

Recombinant B-domain-deleted porcine sequence factor VIII (r- pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitors.

Pilot study on <sup>18</sup>F-FDG PET/CT for detection of inflammatory changes in blood-induced knee arthropathy in a rabbit model.

Instructions to Authors.

Issue Information.

The importance of mRNA structure in determining the pathogenicity of synonymous and non-synonymous mutations in haemophilia.

Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective.

European retrospective study of real-life haemophilia treatment.

Clinical characteristics of two patients with α1-antitrypsin Pittsburgh in a Chinese family.

Prevalence and predictors of loss to follow-up in young adults with mild haemophilia.

Possible assessment of coagulation function and haemostasis therapy using comprehensive coagulation assays in a patient with acquired haemophilia A.

Measuring the quality of haemophilia care across different settings: a set of performance indicators derived from demographics data.

Balance evaluation in haemophilic preadolescent patients using Nintendo Wii Balance Board<sup>®</sup>.

Determining the health-related quality of life in individuals with haemophilia in developing economies: results from the Brazilian population.

Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.

Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein ( rFVIIIFc) in the A-LONG and Kids A- LONG Studies.

Experience of tailoring prophylaxis using factor VIII pharmacokinetic parameters estimated with myPKFiT<sup>®</sup> in patients with severe haemophilia A without inhibitors.

Rapid identification of the intron 22 inversion in haemophilia A.